Mara Klöhn

University Hospitals of the Ruhr-University of Bochum — Germany

Medicine · Health Sciences

13h-index334citations46works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis Viruses Studies and Epidemiology(33), Viral gastroenteritis research and epidemiology(16), Hepatitis C virus research(14), Liver Disease and Transplantation(10), Hepatitis B Virus Studies(9)

Publications46 total

Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium
Liver International·2025· 1 citedOpen Access
The nucleotide analog bemnifosbuvir inhibits hepatitis E virus replication in preclinical models
2025Open Access
Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome
UNC Libraries·2025Open Access
Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome
Nature Communications·2025· 2 citedOpen Access
FRI-263-YI Viral N6-methyladenosine modifications regulate hepatitis E virus infections
Journal of Hepatology·2025
FRI-245-YI Hepatitis E virus entry requires the cholesterol transporter Niemann–Pick C1
Journal of Hepatology·2025
FRI-291-YI Targeting hepatitis E virus with an innovative CRISPR-Cas13-based therapeutic approach
Journal of Hepatology·2025
Host-targeting antivirals for chronic viral infections of the liver
Antiviral Research·2024· 7 citedOpen Access
A Pangenotypic Hepatitis E Virus Replication Inhibitor With High Potency in a Rat Infection Model
Gastroenterology·2024· 3 citedOpen Access
Modeling extrahepatic hepatitis E virus infection in induced human primary neurons
Proceedings of the National Academy of Sciences·2024· 7 citedOpen Access
The glutamate receptor antagonist ifenprodil inhibits hepatitis E virus infection
Antimicrobial Agents and Chemotherapy·2024· 2 citedOpen Access
Hepatitis E virus: from innate sensing to adaptive immune responses
Nature Reviews Gastroenterology & Hepatology·2024· 15 cited
LBP-034 Evaluation of the PIKfyve kinase inhibitor Apilimod against hepatitis E virus infections
Journal of Hepatology·2024
SAT-341 Discovery of a pan-genotypic hepatitis E virus replication inhibitor
Journal of Hepatology·2024
OS-092 Targeting cellular cathepsins inhibits hepatitis E virus infection
Journal of Hepatology·2024
Targeting cellular cathepsins inhibits hepatitis E virus entry
Hepatology·2024· 18 citedOpen Access
Host determinants and responses underlying SARS-CoV-2 liver tropism
Current Opinion in Microbiology·2024· 6 citedOpen Access
Be Aware of the Dog: Tacrolimus Usage and Chronic Hepatitis E Virus Infections
Kidney International Reports·2024· 1 citedOpen Access
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
JHEP Reports·2024· 4 citedOpen Access
Evolution of resistance-associated variants in HEV-patients with sofosbuvir mono- or sofosbuvir-ribavirin combinatory therapy
Zeitschrift für Gastroenterologie·2024
page 1 of 3Next →

Frequent Co-authors

Eike Steinmann(39), Daniel Tödt(30), Yannick Brüggemann(17), André Gömer(13), Michelle Jagst(9), Viet Loan Dao Thi(9), Heiner Wedemeyer(7), Volker Kinast(7), Stephanie Pfaender(6), Patrick Behrendt(6), Rebecca Fu(6), Richard J. P. Brown(6), Natalie Heinen(5), Maximilian K. Nocke(5), Markus Cornberg(5), Jil Alexandra Schrader(5), Sven Pischke(4), Thomas Horvatits(4), Tobias Müller(4), Jungen Hu(4)